These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3187950)

  • 1. Platelet function and the bleeding time in progressive renal failure.
    Gordge MP; Faint RW; Rylance PB; Neild GH
    Thromb Haemost; 1988 Aug; 60(1):83-7. PubMed ID: 3187950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time.
    Gerrard JM; Docherty JC; Israels SJ; Cheang MS; Bishop AJ; Kobrinsky NL; Schroeder ML; Israels ED
    Clin Invest Med; 1989 Jun; 12(3):165-71. PubMed ID: 2787219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
    Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
    J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever.
    Szczeklik A; Milner PC; Birch J; Watkins J; Martin JF
    Thromb Haemost; 1986 Dec; 56(3):283-7. PubMed ID: 3563961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A platelet function defect in preeclampsia.
    Kelton JG; Hunter DJ; Neame PB
    Obstet Gynecol; 1985 Jan; 65(1):107-9. PubMed ID: 3966011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
    Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
    Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of calcium antagonists on bleeding time in patients with chronic renal failure.
    Hayashi K; Matsuda H; Honda M; Ozawa Y; Tokuyama H; Okubo K; Takamatsu I; Kanda T; Tatematsu S; Homma K; Saruta T
    J Hum Hypertens; 2002 Mar; 16(3):199-203. PubMed ID: 11896510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
    Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma beta-thromboglobulin levels in chronic renal failure patients.
    Akizawa T; Nishiyama H; Koshikawa S
    Artif Organs; 1981 Feb; 5(1):54-8. PubMed ID: 6166286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking.
    Hillbom M; Muuronen A; Löwbeer C; Anggård E; Beving H; Kangasaho M
    Thromb Haemost; 1985 Jun; 53(3):419-22. PubMed ID: 4049313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.